These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32463071)

  • 1. Development of an UPSA Short Form for Use in Longitudinal Studies in the Early Alzheimer's Disease Spectrum.
    Goldberg TE; Harvey PD; Devanand DP; Keefe RSE; Gomar JJ
    J Prev Alzheimers Dis; 2020; 7(3):179-183. PubMed ID: 32463071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
    Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
    Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance-based measures of everyday function in mild cognitive impairment.
    Goldberg TE; Koppel J; Keehlisen L; Christen E; Dreses-Werringloer U; Conejero-Goldberg C; Gordon ML; Davies P
    Am J Psychiatry; 2010 Jul; 167(7):845-53. PubMed ID: 20360320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Montreal Cognitive Assessment After Omission of Hearing-Dependent Subtests: Psychometrics and Clinical Recommendations.
    Al-Yawer F; Pichora-Fuller MK; Phillips NA
    J Am Geriatr Soc; 2019 Aug; 67(8):1689-1694. PubMed ID: 31018015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and cross-validation of the UPSA short form for the performance-based functional assessment of patients with mild cognitive impairment and Alzheimer disease.
    Gomar JJ; Harvey PD; Bobes-Bascaran MT; Davies P; Goldberg TE
    Am J Geriatr Psychiatry; 2011 Nov; 19(11):915-22. PubMed ID: 22024615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.
    Harrison JE; Rentz DM; Brashear HR; Arrighi HM; Ropacki MT; Liu E
    J Prev Alzheimers Dis; 2018; 5(4):236-244. PubMed ID: 30298182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric Properties of Alzheimer's Disease Assessment Scale-Cognitive Subscale for Mild Cognitive Impairment and Mild Alzheimer's Disease Patients in an Asian Context.
    Zainal NH; Silva E; Lim LL; Kandiah N
    Ann Acad Med Singap; 2016 Jul; 45(7):273-83. PubMed ID: 27523508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quick test of cognitive speed in older adults with Alzheimer's disease and mild cognitive impairment: A preliminary behavioral and brain imaging study.
    Park S; Pyo S; Shin SA; Lee JY; Kim YK; Park HJ; Youn JH; Park SW; Lee JY
    Psychiatry Res Neuroimaging; 2018 Oct; 280():30-38. PubMed ID: 30145383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spanish version of the Mattis Dementia Rating Scale-2 for early detection of Alzheimer's disease and mild cognitive impairment.
    Boycheva E; Contador I; Fernández-Calvo B; Ramos-Campos F; Puertas-Martín V; Villarejo-Galende A; Bermejo-Pareja F
    Int J Geriatr Psychiatry; 2018 Jun; 33(6):832-840. PubMed ID: 28332732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition.
    Delle Donne V; Ciccarelli N; Massaroni V; Borghetti A; Dusina A; Farinacci D; Visconti E; Tamburrini E; Fabbiani M; Di Giambenedetto S
    J Neurovirol; 2020 Dec; 26(6):899-907. PubMed ID: 32839950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. REMEDES for Alzheimer-R4Alz Battery: Design and Development of a New Tool of Cognitive Control Assessment for the Diagnosis of Minor and Major Neurocognitive Disorders.
    Poptsi E; Tsardoulias E; Moraitou D; Symeonidis AL; Tsolaki M
    J Alzheimers Dis; 2019; 72(3):783-801. PubMed ID: 31640100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological Contribution to Predict Conversion to Dementia in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease.
    Silva D; Cardoso S; Guerreiro M; Maroco J; Mendes T; Alves L; Nogueira J; Baldeiras I; Santana I; de Mendonça A
    J Alzheimers Dis; 2020; 74(3):785-796. PubMed ID: 32083585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognition in MCI and Alzheimer's disease: baseline data from a longitudinal study of the NTB.
    Harrison J; Rentz DM; McLaughlin T; Niecko T; Gregg KM; Black RS; Buchanan J; Liu E; Grundman M;
    Clin Neuropsychol; 2014; 28(2):252-68. PubMed ID: 24521259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
    Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
    J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.
    Zhao A; Li Y; Yan Y; Qiu Y; Li B; Xu W; Wang Y; Liu J; Deng Y
    Transl Neurodegener; 2020 Aug; 9(1):30. PubMed ID: 32741361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison of Serial Position Effects in Patients with Mild Cognitive Impairment due to Parkinson's Disease or to Alzheimer's Disease.
    Meyer A; Handabaka I; Ehrensperger MM; Gschwandtner U; Hatz F; Monsch AU; Stieglitz RD; Fuhr P
    Dement Geriatr Cogn Disord; 2020; 49(2):170-178. PubMed ID: 32634809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a real-world simulated instrument for evaluating visuospatial working memory: a preliminary psychometric study on older adults.
    Mirchi Z; Kheirkhah MT; Khosrowabadi R; Fadardi JS; Ramezani M
    BMC Geriatr; 2024 Jun; 24(1):548. PubMed ID: 38914947
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.